Evidence map›Paper›PMID 37668795›Full record

ArticleJournal of cancer research and clinical oncology2023

Correlation between androgen and estrogen receptor expression and clinicopathologic features in carcinoma urinary bladder.

Nikita Shrivastava, Rahul Jena, Gautam Ram Choudhary, Priyank Bhargava, Vikarn Vishwajeet, Poonam Elhence, Mahendra Singh, Deepak Prakash Bhirud, Arjun Singh Sandhu

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Authors reply Re: Sharma AP, Singh PP, Chauhan R, Panda I, Devana SK, Bora GS,Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  5. Re: Sharma AP, Singh PP, Chauhan R, Panda I, Devana SK, Bora GS,Indian journal of urology : IJU : journal of the Urological Society of India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nikita ShrivastavaDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.ORCID http://orcid.org/0000-0002-0334-0890
Rahul JenaDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.ORCID http://orcid.org/0000-0003-0952-7514
Gautam Ram ChoudharyDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India. gautamoshu@gmail.com.ORCID http://orcid.org/0000-0003-0533-6227
Priyank BhargavaDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.ORCID http://orcid.org/0000-0003-1579-6681
Vikarn VishwajeetDepartment of Pathology, All India Institute of Medical Sciences, Jodhpur, India.
Poonam ElhenceDepartment of Pathology, All India Institute of Medical Sciences, Jodhpur, India.
Mahendra SinghDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.ORCID http://orcid.org/0000-0001-8769-8269
Deepak Prakash BhirudDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.ORCID http://orcid.org/0000-0003-3908-4275
Arjun Singh SandhuDepartment of Urology, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
All India Institute of Medical Sciences Jodhpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe molecular mapping of cancers by the Cancer Genome Atlas Project has accelerated the quest for new therapeutic targets for urinary bladder cancer, including sex steroid receptors. Previous studies have demonstrated conflicting results on their relationship with bladder cancer, and there is sparse data on their expression in the Indian population. The aim of our study is to examine the expression of androgen receptors (AR) and estrogen receptors (ERα and ERβ) in patients with bladder cancer and their correlation with clinicopathologic features. MATERIALS AND

methodsIn this retrospective cohort study, a total of 132 patients, who were surgically managed for urinary bladder mass by transurethral resection or radical cystectomy in our institute, with transitional cell carcinoma on histopathology and with at least two years of follow-up were included. Their demographic and treatment details were obtained, histopathology blocks were retrieved and immunohistochemical staining for androgen and estrogen receptors was performed. Then, the relationship between their expression and clinicopathologic features was studied.

resultsA total of 3.79% of patients showed estrogen receptor alpha positivity, 51.52% estrogen receptor beta positivity and 63.64% androgen receptor positivity. No statistically significant correlation was found between age of patients (p = 0.75/0.52/0.87), tumour stage and grade (0.71/0.3/0.21), pathological variant (p = 1/0.58/0.38) and overall survival (p = 0.70/0.052/0.45 for NMIBC and p = 0.82/0.36/0.22) and estrogen receptor alpha, estrogen receptor beta and androgen receptor-positive status, respectively. Estrogen receptor beta positivity was significantly higher in patients with unifocal (p = 0.015) and small tumours (< 5 cm) (p = 0.03), and its expression was associated with better disease-free survival (DFS) (p = 0.046) in patients of non-muscle invasive bladder cancer (NMIBC).

conclusionOur study has the largest sample size conducted on Indian population with results differing from previous studies conducted on western population. Estrogen receptor beta expression was significantly associated with small unifocal tumours and better DFS. Estrogen receptor alpha and androgen receptor expression were not found to be associated with the clinicopathologic features of the study population.

Indexed as

Carcinoma, Transitional CellUrinary Bladder NeoplasmsAndrogensEstrogen Receptor alphaEstrogen Receptor betaEstrogensHumansPrognosisReceptors, AndrogenReceptors, EstrogenRetrospective StudiesUrinary BladderAndrogensEstrogen Receptor alphaEstrogen Receptor betaEstrogensReceptors, AndrogenReceptors, EstrogenAndrogen receptorEstrogen receptor alphaEstrogen receptor betaUrinary bladder cancer

Identifiers

PMID37668795
PMCPMC11796757
OpenAlexW4386438363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.